FDA official logo
GSRS logo
PFDA official logo

MUROMONAB-CD3

  • UNII: JGA39ICE2V
  • Preferred Substance Name: MUROMONAB-CD3

  • 140608-64-6
  • ANTICD3
  • L04AA02
  • MACS GMP CD3 PURE
  • MUROMOMAB
  • MUROMONAB
  • MUROMONAB CD3
  • MUROMONAB CD3 [MI]
  • MUROMONAB-CD3 [INN]
  • MUROMONAB-CD3 [JAN]
  • MUROMONAB-CD3 [MART.]
  • MUROMONAB-CD3 [USAN]
  • MUROMONAB-CD3 [VANDF]
  • MUROMONAB-CD3 [WHO-DD]
  • OKT3
  • OKT-3
  • ORTHOCLONE OKT3
  • PURIFIED IGG2A IMMUNOGLOBULIN MANUFACTURED INVOLVING FUSION OF MOUSE MYELOMA CELLS TO LYMPHOCYTES FROM IMMUNIZED ANIMALS TO PRODUCE A HYBRIDOMA WHICH SECRETES ANTIGEN-SPECIFIC ANTIBODIES TO THE T3 ANTIGEN OF HUMAN T-LYMPHOCYTES

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.